Skip to content

Dyspnea and Psychosocial Effects of Hand Fan Application in COPD Patients

Effect of Hand Fan Applied to COPD Patients on Dyspnea, Illness Perception, Anxiety and Depression: A Double-Blind Randomized Controlled Experimental Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06857422
Acronym
COPD
Enrollment
59
Registered
2025-03-04
Start date
2025-02-28
Completion date
2025-09-14
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, COPD, Depression, Dyspnea, Illness Perception

Brief summary

This randomized controlled trial aims to evaluate the effects of hand fan application on dyspnea, illness perception, anxiety, and depression in COPD patients. A total of 56 voluntary COPD patients (28 experimental, 28 control) will be recruited from Ardahan State Hospital Chest Diseases Clinic. Patients will be randomly assigned to the experimental or control group. The experimental group will receive a hand fan and use it for 10 minutes daily for six weeks, while the control group will receive standard care. Dyspnea, illness perception, anxiety, and depression will be assessed using the Visual Dyspnea Scale, Illness Perception Questionnaire, and Hospital Anxiety and Depression Scale at baseline and after six weeks. Data will be analyzed using statistical software. This study is expected to contribute to the literature by evaluating a non-pharmacological intervention for COPD-related dyspnea and psychological outcomes.

Interventions

BEHAVIORALHand Fan Application

Participants in the experimental group will be instructed to use a hand fan to cool their face for 10 minutes each day for a period of 6 weeks. The fan should be held approximately 15 cm from the face, focusing on the middle area. This intervention aims to alleviate symptoms of dyspnea and improve psychological well-being, including anxiety, depression, and illness perception. The participants will receive daily reminders to ensure consistent application of the intervention.

OTHERStandard Care for COPD Patients

Participants in the control group will receive standard care for chronic obstructive pulmonary disease (COPD) patients. This includes routine management and treatment as prescribed by their healthcare providers, such as medication and lifestyle recommendations. They will not be instructed to use a hand fan or any other cooling device during the study period. The control group will continue their regular care without any additional interventions from the research team.

Sponsors

Ardahan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Blinding will be done for the researcher, participants and statistician.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Orientation and cooperation * No communication problems

Exclusion criteria

* Having a COPD exacerbation in the last 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
Dyspnea SeverityPre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement).The primary outcome measure of this study will be the severity of dyspnea, assessed using the Visual Analog Scale (VAS). This scale is a subjective tool used to measure the intensity of shortness of breath experienced by participants.

Secondary

MeasureTime frameDescription
Illness PerceptionPre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement).Measured using the Illness Perception Questionnaire
Anxiety and DepressionPre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement).Measured using the Hospital Anxiety and Depression Scale (HADS)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026